Home / MissionIR Articles / Astex Pharmaceuticals, Inc. (ASTX) Starts Presentation at 25th Annual ROTH Conference

Astex Pharmaceuticals, Inc. (ASTX) Starts Presentation at 25th Annual ROTH Conference

Astex Pharmaceuticals is a pharmaceutical company focused on the discovery and development of novel small molecule therapeutics, with a focus on oncology. The company is currently engaged in developing a proprietary pipeline of novel therapies and is creating de-risked products for partnership with leading pharmaceutical companies. The company developed Dacogen (decitabine) for injection and receives significant royalties for its worldwide sales. For more information, visit the company’s Web site: http://www.astx.com

Let us hear your thoughts below: